JP2010132654A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010132654A5 JP2010132654A5 JP2009258219A JP2009258219A JP2010132654A5 JP 2010132654 A5 JP2010132654 A5 JP 2010132654A5 JP 2009258219 A JP2009258219 A JP 2009258219A JP 2009258219 A JP2009258219 A JP 2009258219A JP 2010132654 A5 JP2010132654 A5 JP 2010132654A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- oral administration
- solid preparation
- excipient
- lactose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 6
- 239000007787 solid Substances 0.000 claims 6
- 238000002360 preparation method Methods 0.000 claims 5
- 229920002472 Starch Polymers 0.000 claims 4
- 239000008101 lactose Substances 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 4
- 239000008107 starch Substances 0.000 claims 4
- 235000019698 starch Nutrition 0.000 claims 4
- 239000001913 cellulose Substances 0.000 claims 3
- 229920002678 cellulose Polymers 0.000 claims 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
- 239000011230 binding agent Substances 0.000 claims 2
- GPPJWWMREQHLQT-BHQIMSFRSA-N cariprazine hydrochloride Chemical compound Cl.C1C[C@@H](NC(=O)N(C)C)CC[C@@H]1CCN1CCN(C=2C(=C(Cl)C=CC=2)Cl)CC1 GPPJWWMREQHLQT-BHQIMSFRSA-N 0.000 claims 2
- 229960003429 cariprazine hydrochloride Drugs 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- 229920001817 Agar Polymers 0.000 claims 1
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 1
- 239000001856 Ethyl cellulose Substances 0.000 claims 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 1
- 239000008272 agar Substances 0.000 claims 1
- 229940023476 agar Drugs 0.000 claims 1
- 238000000748 compression moulding Methods 0.000 claims 1
- 229960001681 croscarmellose sodium Drugs 0.000 claims 1
- 229960000913 crospovidone Drugs 0.000 claims 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 229920001249 ethyl cellulose Polymers 0.000 claims 1
- 235000019325 ethyl cellulose Nutrition 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229940069328 povidone Drugs 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229940032147 starch Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009258219A JP2010132654A (ja) | 2008-02-21 | 2009-11-11 | 経口投与用固形製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008040696 | 2008-02-21 | ||
| JP2008284685 | 2008-11-05 | ||
| JP2009258219A JP2010132654A (ja) | 2008-02-21 | 2009-11-11 | 経口投与用固形製剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009520724A Division JP4409630B2 (ja) | 2008-02-21 | 2009-02-20 | 経口投与用固形製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010132654A JP2010132654A (ja) | 2010-06-17 |
| JP2010132654A5 true JP2010132654A5 (enExample) | 2012-04-05 |
Family
ID=40985616
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009520724A Active JP4409630B2 (ja) | 2008-02-21 | 2009-02-20 | 経口投与用固形製剤 |
| JP2009258219A Pending JP2010132654A (ja) | 2008-02-21 | 2009-11-11 | 経口投与用固形製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009520724A Active JP4409630B2 (ja) | 2008-02-21 | 2009-02-20 | 経口投与用固形製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20110059980A1 (enExample) |
| EP (1) | EP2251011B1 (enExample) |
| JP (2) | JP4409630B2 (enExample) |
| KR (2) | KR20130115393A (enExample) |
| CN (1) | CN102014909B (enExample) |
| AT (1) | ATE552002T1 (enExample) |
| CA (1) | CA2715760C (enExample) |
| EA (1) | EA023972B1 (enExample) |
| WO (1) | WO2009104739A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0700353A2 (en) * | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
| US7875610B2 (en) * | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
| EA023972B1 (ru) * | 2008-02-21 | 2016-08-31 | Рихтер Гедеон Нирт. | Стабильный твёрдый препарат карипразина для перорального введения и способ его получения |
| HRP20150196T1 (hr) | 2008-07-16 | 2015-06-05 | Richter Gedeon Nyrt. | Farmaceutske formulacije s ligandima receptora dopamina |
| HU230067B1 (hu) | 2008-12-17 | 2015-06-29 | Richter Gedeon Nyrt | Új piperazin só és eljárás előállítására |
| HUP0800765A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
| HUP0800766A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Vegyeszet | Process for the preparation of piperazine derivatives |
| CN106560179B (zh) * | 2015-09-30 | 2020-02-21 | 石药集团中奇制药技术（石家庄）有限公司 | 盐酸卡利拉嗪药物组合物及其制备方法 |
| EP3231418A1 (en) * | 2016-04-14 | 2017-10-18 | Richter Gedeon Nyrt. | Granule formulation for oral administration |
| KR20190022709A (ko) * | 2016-06-28 | 2019-03-06 | 가부시키가이샤 니폰 고킨 소고 겐큐쇼 | 부형제 및 정제 |
| US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
| CN107970217A (zh) * | 2016-10-25 | 2018-05-01 | 浙江京新药业股份有限公司 | 卡利拉嗪口腔崩解片及其制备方法 |
| CN108261394B (zh) * | 2017-01-04 | 2022-03-04 | 广东东阳光药业有限公司 | 一种盐酸卡利拉嗪注射制剂及其制备方法和用途 |
| HUP1700253A1 (hu) * | 2017-06-13 | 2019-01-28 | Richter Gedeon Nyrt | Szilárd orális gyógyszerkészítmények |
| US11273156B2 (en) * | 2018-11-20 | 2022-03-15 | Aurobindo Pharma Ltd | Stable cariprazine formulations for oral use |
| US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
| US11344503B2 (en) * | 2019-12-13 | 2022-05-31 | Halo Science LLC | Cariprazine release formulations |
| JP2023536341A (ja) * | 2020-08-06 | 2023-08-24 | エスケー バイオファーマスティカルズ カンパニー リミテッド | カルバメート化合物を含む経口用固形製剤及びその製造方法 |
| CN118526462B (zh) * | 2024-07-25 | 2024-11-15 | 山东则正医药技术有限公司 | 不同规格溶出行为相似的盐酸卡利拉嗪口崩片及制备方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4666911A (en) * | 1981-07-14 | 1987-05-19 | Taiho Pharmaceutical Company Limited | Allophanoylpiperazine compound and analgesic composition containing same as active ingredient |
| GB8802622D0 (en) * | 1988-02-05 | 1988-03-02 | Glaxo Group Ltd | Chemical compound |
| US4957921A (en) * | 1989-12-06 | 1990-09-18 | Warner-Lambert Company | Substituted cyclohexanols as central nervous system agents |
| AU707748B2 (en) * | 1994-03-25 | 1999-07-22 | Isotechnika Inc. | Enhancement of the efficacy of drugs by deuteration |
| US6334997B1 (en) * | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| US6528529B1 (en) * | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| AU742720B2 (en) * | 1998-06-30 | 2002-01-10 | Zeria Pharmaceutical Co., Ltd. | N-phenyl-N'-phenylpropylpiperazine derivatives and process for the preparation thereof |
| US6489341B1 (en) * | 1999-06-02 | 2002-12-03 | Sepracor Inc. | Methods for the treatment of neuroleptic and related disorders using sertindole derivatives |
| BR0207832A (pt) * | 2001-02-27 | 2004-06-22 | Ortho Mcneil Pharm Inc | Compostos de carbamato para uso na prevenção ou tratamento de distúrbio bipolar |
| US6566550B2 (en) * | 2001-06-21 | 2003-05-20 | Pfizer Inc | Substituted aromatic ethers as inhibitors of glycine transport |
| HU227543B1 (en) * | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
| US6919342B2 (en) * | 2003-06-05 | 2005-07-19 | Abbott Gmbh & Co. Kg | Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| HU227534B1 (en) * | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
| DE102004047517A1 (de) * | 2004-09-28 | 2006-03-30 | Merck Patent Gmbh | Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid |
| PL2155200T3 (pl) * | 2007-05-11 | 2017-06-30 | Richter Gedeon Nyrt. | Postać krystaliczna pochodnej karbamoilo-cykloheksanu |
| HU230748B1 (hu) * | 2007-05-11 | 2018-02-28 | Richter Gedeon Nyrt | Új piperazin só és előállítási eljárása |
| HUP0700353A2 (en) * | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
| HUP0700370A2 (en) * | 2007-05-24 | 2009-04-28 | Richter Gedeon Nyrt | Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania |
| HUP0700369A2 (en) * | 2007-05-24 | 2009-04-28 | Richter Gedeon Nyrt | Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment in the manufacture of a medicament for the treatment of schizophrenia |
| MX2010001171A (es) * | 2007-08-01 | 2010-03-01 | Lundbeck & Co As H | Uso de abridores de canales de potasio kcnq para reducir los sintomas o tratar desordenes o afecciones en las cuales se encuentra anulado el sistema dopaminergico. |
| US7875610B2 (en) * | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
| EA023972B1 (ru) * | 2008-02-21 | 2016-08-31 | Рихтер Гедеон Нирт. | Стабильный твёрдый препарат карипразина для перорального введения и способ его получения |
| HRP20150196T1 (hr) * | 2008-07-16 | 2015-06-05 | Richter Gedeon Nyrt. | Farmaceutske formulacije s ligandima receptora dopamina |
| HU230067B1 (hu) * | 2008-12-17 | 2015-06-29 | Richter Gedeon Nyrt | Új piperazin só és eljárás előállítására |
| HUP0800765A2 (en) * | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
| HUP0800766A2 (en) * | 2008-12-18 | 2010-11-29 | Richter Gedeon Vegyeszet | Process for the preparation of piperazine derivatives |
-
2009
- 2009-02-20 EA EA201001334A patent/EA023972B1/ru unknown
- 2009-02-20 JP JP2009520724A patent/JP4409630B2/ja active Active
- 2009-02-20 CA CA2715760A patent/CA2715760C/en not_active Expired - Fee Related
- 2009-02-20 AT AT09712557T patent/ATE552002T1/de active
- 2009-02-20 US US12/918,580 patent/US20110059980A1/en not_active Abandoned
- 2009-02-20 CN CN2009801148592A patent/CN102014909B/zh active Active
- 2009-02-20 EP EP09712557A patent/EP2251011B1/en active Active
- 2009-02-20 WO PCT/JP2009/053039 patent/WO2009104739A1/ja not_active Ceased
- 2009-02-20 KR KR1020137025458A patent/KR20130115393A/ko not_active Ceased
- 2009-02-20 KR KR1020107020649A patent/KR101563383B1/ko active Active
- 2009-11-11 JP JP2009258219A patent/JP2010132654A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010132654A5 (enExample) | ||
| SG10201407947WA (en) | Compressible-coated pharmaceutical compositions and tablets and methods of manufacture | |
| AR069031A1 (es) | Composicion | |
| JP2018507200A5 (enExample) | ||
| JP2010047612A5 (enExample) | ||
| FI4159205T3 (fi) | Uudenlainen farmaseuttinen koostumus | |
| JP2014532638A5 (enExample) | ||
| JP2014167026A5 (enExample) | ||
| JP2017523206A5 (enExample) | ||
| HRP20171578T1 (hr) | Čvrsta disperzija | |
| JO3753B1 (ar) | قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه | |
| RU2016144479A (ru) | Фармацевтические композиции для лечения заболеваний, опосредопосредованных муковисцидозным трансмембранным регулятором проводимости | |
| JP2006077018A5 (enExample) | ||
| JP2015511635A5 (enExample) | ||
| JP2003231634A5 (enExample) | ||
| PE20161072A1 (es) | Formulacion compuesta para administracion oral que comprende ezetimibe y rosuvastatina | |
| RU2016117186A (ru) | Комбинированная композиция, содержащая тадалафил и амлодипин | |
| RU2006133902A (ru) | Твердые препаративные формы оспемифена | |
| JP2005530787A5 (enExample) | ||
| JP2007523210A5 (enExample) | ||
| AR100977A1 (es) | Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación | |
| JP2013502452A (ja) | オチロニウムの直接圧縮錠 | |
| US20160303077A1 (en) | Novel compositions | |
| JP2016108327A5 (enExample) | ||
| JP2009539797A5 (enExample) |